Mitigating potential risk for stakeholders in light of latest Sunshine Act developments.
Kim Schroer
Advertisement
Articles by Kim Schroer
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
2
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference?
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
JP Morgan 2026: Regeneron Focusing on Broad Pipeline Development
5